Skip to main content
Clinical Trials/CTRI/2023/02/049847
CTRI/2023/02/049847
Completed
Phase 3

A prospective clinical study on the Homoeopathic medicine Lycopodium 200 in the management of Diabetic Distal Symmetric Polyneuropathy (DDSP)

Dr. Simran Samdani0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Sponsor
Dr. Simran Samdani
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr. Simran Samdani

Eligibility Criteria

Inclusion Criteria

  • Both male and female suffering from diabetes mellitus on allopatic management.
  • DDSPSAS \>2
  • Controlled hypertension.
  • Previously diagnosed case.
  • Written informed consent.

Exclusion Criteria

  • Diabetic Mononeuropathy, polyradiculopathy, amyothrophy, autonomic neuropathy, abnormalities of gait,wrist/foot drop, paralysis of cranial nerves.
  • MI within 6 months, unstable angina.
  • Neuropathy due to other causes, Vit B12 deficiency, alcoholism
  • Diabetic complications\- retinopathy, renal involvement, recurrent hypoglycemia, ketoacidosis.
  • Other systemic disease\- CVS , endocrinal, systemic infections or on other treatment (except HTN)

Outcomes

Primary Outcomes

Not specified

Similar Trials